[1]
Dalkh, T., Naranbat, N., Bayarsaikhan, E., Damba, T.-A. and Byambaaa, T. 2018. Effects of Hepaclin-4 on Hepatocellular Carcinoma (Hep G2). Central Asian Journal of Medical Sciences. 4, 1 (Mar. 2018), 48–54. DOI:https://doi.org/10.24079/cajms.2018.03.006.